Global Biologics and Biosimilars Market 2018 Industry Key Players, Share, Trend, Segmentation and Forecast to 2023

PUNE, INDIA, March 9, 2018 /EINPresswire.com/ -- Summary

WiseGuyReports.com adds “Biologics and Biosimilars Market 2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2023” reports to its database.

This report provides in depth study of “Biologics and Biosimilars Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Biologics and Biosimilars Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.A biosimilar in this report is a biologic medical product which is copy of an original product that is manufactured by a different company. Biosimilars are officially approved versions of original “innovator” products, and can be manufactured when the original product's patent expires.

Global and Regional Biologics and Biosimilars market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Roche
Amgen
AbbVie
Sanofi-Aventis
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck
3sbio
Changchun High Tech
CP Guojian
Biotech
Gelgen
Innovent
Dong Bao
Ganlee
United Laboratories

Market Segment as follows:
By Region
Asia-Pacific
North America
Europe
South America
Middle East & Africa

By Type
Antibody
Hormone
Growth Factors
Other

By Application
Tumor
Diabetes
Cardiovascular
Hemophilia
Others

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/2496466-global-and-regional-biologics-and-biosimilars-market-research-report-2017

Table of Contents

1 Market Overview
1.1 Market Segment Overview
1.1.1 Product Definition
1.1.2 Market by Type
1.1.2.1 Antibody
1.1.2.2 Hormone
1.1.2.3 Growth Factors
1.1.2.4 Other
1.1.3 Market by Application
1.1.3.1 Tumor
1.1.3.2 Diabetes
1.1.3.3 Cardiovascular
1.1.3.4 Hemophilia
1.1.3.5 Others
1.2 Global and Regional Market Size
1.2.1 Global Overview
1.2.2 Market by Region
1.2.2.1 Asia-Pacific
1.2.2.2 North America
1.2.2.3 Europe
1.2.2.4 South America
1.2.2.5 Middle East & Africa

…..

6 Key Manufacturers
6.1 Roche
6.1.2 Company Information
6.1.2 Product Specifications
6.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.2 Amgen
6.2.1 Company Information
6.2.2 Product Specifications
6.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.3 AbbVie
6.3.1 Company Information
6.3.2 Product Specifications
6.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.4 Sanofi-Aventis
6.4.1 Company Information
6.4.2 Product Specifications
6.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.5 Johnson & Johnson
6.5.1 Company Information
6.5.2 Product Specifications
6.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.6 Pfizer
6.6.1 Company Information
6.6.2 Product Specifications
6.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.7 Novo Nordisk
6.7.1 Company Information
6.7.2 Product Specifications
6.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.8 Eli Lilly
6.8.1 Company Information
6.8.2 Product Specifications
6.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.9 Novartis
6.9.1 Company Information
6.9.2 Product Specifications
6.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.10 Merck
6.10.1 Company Information
6.10.2 Product Specifications
6.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.11 3sbio
6.12 Changchun High Tech
6.13 CP Guojian
6.14 Biotech
6.15 Gelgen
6.16 Innovent
6.17 Dong Bao
6.18 Ganlee
6.19 United Laboratories

At any Query @ https://www.wiseguyreports.com/enquiry/2496466-global-and-regional-biologics-and-biosimilars-market-research-report-2017

Continued....

Ph: +1-646-845-9349 (US) ; Ph: +44 208 133 9349 (UK)

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here

Distribution channels: Business & Economy, Education, Healthcare & Pharmaceuticals Industry, Science, U.S. Politics

EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release